Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Using an API to commercialize an evidence based weight loss intervention

    SBC: COEUS HEALTH, LLC            Topic: 300

    DESCRIPTION provided by applicant Over percent of the U S population is currently overweight or obese percent are obese Obesity is a primary cause of numerous chronic diseases including type II diabetes cancer heart disease and the metabolic syndrome Behavioral weight loss interventions have successfully resulted in significant clinical improvements in weight percent weight lo ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Microfabricated Cochlear Electrode Array

    SBC: MEMStim LLC            Topic: NIDCD

    Project Summary Abstract Current cochlear implants while beneficial in their use are limited in their capabilities by hand assembly of the electrode arrays This tedious manufacturing method is very costly extremely labor intensive and inadequate in implementing new technologies for improving speech recognition and music appreciation A superior alternative to hand assembly is microfabricati ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Newborn Infant Vision Test

    SBC: Precision Vision, Inc.            Topic: N

    Project Summary! This STTR Phase II project continues the development of the Newborn Acuity Cardstm and the Newborn Contrast Cardstm Together these Newborn Cards form a new clinical test of visual acuity and contrast sensi tivity for use on newborn full term and preterm infants The stimuli are square wave gratings which the examiner presents to the infant in a fixation and following protocol ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Aminomethyl benzamides as novel anti Ebola agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Ebola EBOV and Marburg MARV viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral infection and pathogenes ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Better Living After Stroke through Technology BLAST

    SBC: BRIGHTOUTCOME INC.            Topic: 600

    DESCRIPTION provided by applicant Stroke the leading cause of disability cognitive impairment and death in the US imposes significant financial and personal burden The residual effects of stroke affect many aspects of life not addressed by traditional rehabilitation treatments In particular persons with mild stroke typically defined as a stroke with no or sligh motor impairment and a high ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Aminopiperidines as novel anti influenza agents

    SBC: Chicago Biosolutions, Inc.            Topic: NIAID

    Influenza A viruses belong to the orthomyxoviridae family with a negative sense segmented RNA genome which can cause seasonal or pandemic flu with high morbidity and significant mortality Vaccination is the most prevalent prophylactic means for controlling influenza infections However an effective vaccine usually takes at least months to develop for the circulating strains Furthermore vac ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Salud Juntos A Promotora Led Home Based Cancer Care Support Solution

    SBC: BRIGHTOUTCOME INC.            Topic: 102

    DESCRIPTION provided by applicant This application is in response to RFA EB a special SBIR program to reduce health disparities by developing medical technologies that are andquot effective affordable culturally acceptable and easily accessible to those who need them andquot It is based on the well established partnership between BrightOutcome and Dr Ana Maria Lopez Associate Vice ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. A Proton Radiography System for Optimization of Proton Therapy

    SBC: ProtonVDA LLC            Topic: 102

    Proton radiography produces images of patients in terms of proton stopping power by tracking individual protons before and after the patient and measuring the proton residual range after traversing the patient and would be the most direct method of image guidance for proton radiation therapy Radiation therapy is needed for more than of the million Americans who are annually diagnosed wi ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. An Alternative Concrete Chemistry with Significantly Enhanced Durability, Sustainability, Economy, Safety and Strength

    SBC: METNA CO            Topic: 14NCER5A

    Manufacturing of Portland cement, the primary binder in concrete, accounts for ~7% of global CO2 emissions, 4% of energy use, and exhaustion of natural resources. Premature aging of concrete in infrastructure systems is another major concern.  A robust binder chemistry has been developed to overcome these drawbacks.  The original approach to production of this binder, however, is not compatible ...

    SBIR Phase II 2016 Environmental Protection Agency
  10. NanoCytology to mitigate overdiagnosis of prostate cancer

    SBC: NANOCYTOMICS LLC            Topic: 102

    DESCRIPTION provided by applicant Prostate cancer is the leading cancer among U S men The biggest limitation of current prostate cancer management is that currently it is essentially impossible to accurately prognosticate which patients harbor aggressive cancers that progress into a metastatic disease and need treatment and which patients have non aggressive indolent cancers that would not ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government